trending Market Intelligence /marketintelligence/en/news-insights/trending/tveusoeok3vuyc756lr6jg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Device-maker Medartis prices Swiss IPO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Device-maker Medartis prices Swiss IPO

Basel, Switzerland-based Medartis AG priced its IPO at CHF48 per share, in the middle of the indicated range of CHF44 per share to CHF54 per share, Reuters reported.

The pricing suggests a market capitalization of CHF563 million, plus a free float of 24.6%, including the overallotment option.

The medical device-maker will use gross proceeds of about CHF123.9 million, or CHF142.6 million including the overallotment shares, to fund its growth.

The shares will start trading on the SIX Swiss Exchange beginning March 23.

Medartis makes metal implants for the surgical fixation of bone fractures.